vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.

Resolute Holdings Management, Inc. is the larger business by last-quarter revenue ($117.7M vs $85.1M, roughly 1.4× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -1.5%, a 24.3% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $28.5M).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.

FDMT vs RHLD — Head-to-Head

Bigger by revenue
RHLD
RHLD
1.4× larger
RHLD
$117.7M
$85.1M
FDMT
Higher net margin
FDMT
FDMT
24.3% more per $
FDMT
22.8%
-1.5%
RHLD
More free cash flow
RHLD
RHLD
$160.7M more FCF
RHLD
$189.2M
$28.5M
FDMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FDMT
FDMT
RHLD
RHLD
Revenue
$85.1M
$117.7M
Net Profit
$19.4M
$-1.7M
Gross Margin
55.7%
Operating Margin
17.3%
30.2%
Net Margin
22.8%
-1.5%
Revenue YoY
8508900.0%
Net Profit YoY
139.1%
EPS (diluted)
$0.43
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
RHLD
RHLD
Q4 25
$85.1M
$117.7M
Q3 25
$90.0K
$120.9M
Q2 25
$15.0K
$119.6M
Q1 25
$14.0K
$103.9M
Q4 24
$1.0K
Q3 24
$3.0K
Q2 24
$5.0K
Q1 24
$28.0K
Net Profit
FDMT
FDMT
RHLD
RHLD
Q4 25
$19.4M
$-1.7M
Q3 25
$-56.9M
$-231.0K
Q2 25
$-54.7M
$-611.0K
Q1 25
$-48.0M
$-3.4M
Q4 24
Q3 24
$-43.8M
Q2 24
$-35.0M
Q1 24
$-32.4M
Gross Margin
FDMT
FDMT
RHLD
RHLD
Q4 25
55.7%
Q3 25
59.0%
Q2 25
57.5%
Q1 25
52.5%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
FDMT
FDMT
RHLD
RHLD
Q4 25
17.3%
30.2%
Q3 25
-67983.3%
34.3%
Q2 25
-396373.3%
34.0%
Q1 25
-383007.1%
24.7%
Q4 24
Q3 24
-1704400.0%
Q2 24
-849120.0%
Q1 24
-136200.0%
Net Margin
FDMT
FDMT
RHLD
RHLD
Q4 25
22.8%
-1.5%
Q3 25
-63195.6%
-0.2%
Q2 25
-364386.7%
-0.5%
Q1 25
-342657.1%
-3.2%
Q4 24
Q3 24
-1461433.3%
Q2 24
-699060.0%
Q1 24
-115717.9%
EPS (diluted)
FDMT
FDMT
RHLD
RHLD
Q4 25
$0.43
$-0.20
Q3 25
$-1.01
$-0.03
Q2 25
$-0.98
$-0.07
Q1 25
$-0.86
$-0.39
Q4 24
Q3 24
$-0.79
Q2 24
$-0.63
Q1 24
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
RHLD
RHLD
Cash + ST InvestmentsLiquidity on hand
$402.7M
$205.5M
Total DebtLower is stronger
$169.8M
Stockholders' EquityBook value
$505.7M
$6.5M
Total Assets
$566.7M
$333.4M
Debt / EquityLower = less leverage
26.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
RHLD
RHLD
Q4 25
$402.7M
$205.5M
Q3 25
$305.1M
$148.0M
Q2 25
$293.2M
$99.9M
Q1 25
$321.4M
$71.0M
Q4 24
$424.9M
Q3 24
$501.9M
Q2 24
$541.9M
Q1 24
$525.9M
Total Debt
FDMT
FDMT
RHLD
RHLD
Q4 25
$169.8M
Q3 25
$173.4M
Q2 25
$177.1M
Q1 25
$180.7M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FDMT
FDMT
RHLD
RHLD
Q4 25
$505.7M
$6.5M
Q3 25
$369.0M
$10.8M
Q2 25
$420.9M
$9.6M
Q1 25
$469.7M
$8.9M
Q4 24
$510.6M
Q3 24
$552.9M
Q2 24
$588.3M
Q1 24
$600.6M
Total Assets
FDMT
FDMT
RHLD
RHLD
Q4 25
$566.7M
$333.4M
Q3 25
$424.0M
$293.2M
Q2 25
$473.6M
$253.3M
Q1 25
$515.7M
$214.3M
Q4 24
$560.4M
Q3 24
$604.0M
Q2 24
$620.1M
Q1 24
$629.9M
Debt / Equity
FDMT
FDMT
RHLD
RHLD
Q4 25
26.03×
Q3 25
16.01×
Q2 25
18.42×
Q1 25
20.38×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
RHLD
RHLD
Operating Cash FlowLast quarter
$28.6M
$196.1M
Free Cash FlowOCF − Capex
$28.5M
$189.2M
FCF MarginFCF / Revenue
33.5%
160.8%
Capex IntensityCapex / Revenue
0.1%
5.8%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M
$313.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
RHLD
RHLD
Q4 25
$28.6M
$196.1M
Q3 25
$-46.5M
$59.6M
Q2 25
$-43.4M
$48.9M
Q1 25
$-47.8M
$18.4M
Q4 24
$-134.6M
Q3 24
$-29.4M
Q2 24
$-30.2M
Q1 24
$-29.1M
Free Cash Flow
FDMT
FDMT
RHLD
RHLD
Q4 25
$28.5M
$189.2M
Q3 25
$-46.6M
$58.6M
Q2 25
$-43.4M
$47.5M
Q1 25
$-48.4M
$17.8M
Q4 24
$-138.4M
Q3 24
$-31.2M
Q2 24
$-30.6M
Q1 24
$-29.8M
FCF Margin
FDMT
FDMT
RHLD
RHLD
Q4 25
33.5%
160.8%
Q3 25
-51765.6%
48.5%
Q2 25
-289620.0%
39.7%
Q1 25
-345635.7%
17.1%
Q4 24
-13837100.0%
Q3 24
-1038966.7%
Q2 24
-611840.0%
Q1 24
-106421.4%
Capex Intensity
FDMT
FDMT
RHLD
RHLD
Q4 25
0.1%
5.8%
Q3 25
101.1%
0.8%
Q2 25
440.0%
1.2%
Q1 25
4507.1%
0.6%
Q4 24
378600.0%
Q3 24
59266.7%
Q2 24
6980.0%
Q1 24
2535.7%
Cash Conversion
FDMT
FDMT
RHLD
RHLD
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons